T 2437/13 (Coronavirus/AMSTERDAM INSTITUTE) of 19.06.2019
- European Case Law Identifier
- ECLI:EP:BA:2019:T243713.20190619
- Date of decision
- 19 June 2019
- Case number
- T 2437/13
- Petition for review of
- -
- Application number
- 04077342.6
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Coronavirus, nucleic acid, protein and methods for the generation of vaccine, medicaments and diagnostics
- Applicant name
- Amsterdam Institute of Viral Genomics B.V.
- Opponent name
- Pathofinder B.V.
- Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(1)European Patent Convention Art 123(2)European Patent Convention Art 53(c)European Patent Convention Art 54(3)European Patent Convention Art 56European Patent Convention Art 83European Patent Convention Art 84European Patent Convention Art 87European Patent Convention R 3(3)Rules of procedure of the Boards of Appeal Art 13
- Keywords
- New main request - admission into the proceedings (yes)
Admission of documents D12 and D49 to D51 (no)
Amendments - allowable (yes)
Claims - clarity (yes)
Exceptions to patentability - (no)
Sufficiency of disclosure - (yes)
Priority - (yes)
Novelty - main request (yes)
Inventive step - main request (yes) - Catchword
- -
- Cited cases
- T 0156/91T 0727/95T 0074/98T 0839/01T 0820/04T 0708/05T 1186/05T 0871/08T 1715/08T 1499/09
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside
2. The case is remitted to the opposition division with the order to maintain the patent on the basis of claims 1 to 39 of the main request filed at the oral proceedings and a description to be adapted.